Suchergebnisse - "Fujiyama, Shunichiro"

PubPharm (6)

1

Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma

enthalten in: Clinical journal of gastroenterology | 2023

von Kawamura, Y. | Akuta, N. | Shindoh, J. | +14

ErratumIn: Clin J Gastroenterol. 2023 Oct;16(5):791. - PMID 37392310

2

The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment : An Imaging-Based Analysis

enthalten in: Oncology | 2023

von Muraishi, N. | Kawamura, Y. | Akuta, N. | +14

3

Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment

enthalten in: Internal medicine (Tokyo, Japan) | 2022

von Muraishi, N. | Kawamura, Y. | Kobayashi, M. | +16

4

Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib

enthalten in: Internal medicine (Tokyo, Japan) | 2021

von Kasuya, K. | Kawamura, Y. | Kobayashi, M. | +16

CommentIn: Intern Med. 2021 Feb 1;60(3):321-322. - PMID 32963171

5

Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment

enthalten in: Oncology | 2021

von Yamashige, D. | Kawamura, Y. | Kobayashi, M. | +17

6

Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment

enthalten in: Oncology | 2021

von Kawamura, Y. | Kobayashi, M. | Shindoh, J. | +15

1
[1]